Palbociclib in combination with letrozole as first or later line therapy for patients with locally advanced, inoperable or metastatic HR+/ HER2-breast cancer in Germany: Interim results of the INGE-B phase II study

Annals of Oncology(2018)

引用 0|浏览23
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要